{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:22:24Z","timestamp":1790662944781,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T00:00:00Z","timestamp":1277337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10689-010-9356-3","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T12:43:29Z","timestamp":1277297009000},"page":"625-633","source":"Crossref","is-referenced-by-count":38,"title":["Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations"],"prefix":"10.1007","volume":"9","author":[{"given":"Xiaohong Rose","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chanock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa M.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,24]]},"reference":[{"issue":"20","key":"9356_CR1","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/sj.onc.1206444","volume":"22","author":"MA Tucker","year":"2003","unstructured":"Tucker MA, Goldstein AM (2003) Melanoma etiology: where are we? Oncogene 22(20):3042\u20133052","journal-title":"Oncogene"},{"issue":"3","key":"9356_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.jid.5700094","volume":"126","author":"MJ Eliason","year":"2006","unstructured":"Eliason MJ, Larson AA, Florell SR et al (2006) Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol 126(3):660\u2013666","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9356_CR3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/humu.9247","volume":"23","author":"AM Goldstein","year":"2004","unstructured":"Goldstein AM (2004) Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 23(6):630","journal-title":"Hum Mutat"},{"issue":"2","key":"9356_CR4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cancergencyto.2008.01.008","volume":"182","author":"Z Rakosy","year":"2008","unstructured":"Rakosy Z, Vizkeleti L, Ecsedi S et al (2008) Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet Cytogenet 182(2):116\u2013121","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"9356_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.ejhg.5201729","volume":"15","author":"G Zhu","year":"2007","unstructured":"Zhu G, Montgomery GW, James MR et al (2007) A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions. Eur J Hum Genet 15(1):94\u2013102","journal-title":"Eur J Hum Genet"},{"issue":"20","key":"9356_CR6","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1093\/hmg\/ddl227","volume":"15","author":"M Falchi","year":"2006","unstructured":"Falchi M, Spector TD, Perks U, Kato BS, Bataille V (2006) Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort. Hum Mol Genet 15(20):2975\u20132979","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9356_CR7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/(SICI)1098-2264(199705)19:1<52::AID-GCC8>3.0.CO;2-#","volume":"19","author":"L Liu","year":"1997","unstructured":"Liu L, Goldstein AM, Tucker MA et al (1997) Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF. Genes Chromosomes Cancer 19(1):52\u201354","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"9356_CR8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00008390-200312000-00006","volume":"13","author":"M Casula","year":"2003","unstructured":"Casula M, Ascierto PA, Cossu A et al (2003) Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9P21. Melanoma Res 13(6):571\u2013579","journal-title":"Melanoma Res"},{"issue":"16","key":"9356_CR9","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1073\/pnas.93.16.8541","volume":"93","author":"MG FitzGerald","year":"1996","unstructured":"FitzGerald MG, Harkin DP, Silva-Arrieta S et al (1996) Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc Natl Acad Sci USA 93(16):8541\u20138545","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9356_CR10","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-2004","volume":"67","author":"E Pasmant","year":"2007","unstructured":"Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I (2007) Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67(8):3963\u20133969","journal-title":"Cancer Res"},{"issue":"8","key":"9356_CR11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ng.411","volume":"41","author":"DT Bishop","year":"2009","unstructured":"Bishop DT, Demenais F, Iles MM et al (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41(8):920\u2013925","journal-title":"Nat Genet"},{"issue":"8","key":"9356_CR12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ng.410","volume":"41","author":"M Falchi","year":"2009","unstructured":"Falchi M, Bataille V, Hayward NK et al (2009) Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 41(8):915\u2013919","journal-title":"Nat Genet"},{"issue":"2","key":"9356_CR13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jcb.21984","volume":"106","author":"AP Stevens","year":"2009","unstructured":"Stevens AP, Spangler B, Wallner S et al (2009) Direct and tumor microenvironment mediated influences of 5\u2032-deoxy-5\u2032-(methylthio)adenosine on tumor progression of malignant melanoma. J Cell Biochem 106(2):210\u2013219","journal-title":"J Cell Biochem"},{"issue":"1","key":"9356_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","volume":"14","author":"JM Kirkwood","year":"1996","unstructured":"Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH (1996) Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14(1):7\u201317","journal-title":"J Clin Oncol"},{"issue":"9","key":"9356_CR15","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1158\/1055-9965.EPI-05-0321A","volume":"14","author":"AM Goldstein","year":"2005","unstructured":"Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA (2005) Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomark Prev 14(9):2208\u20132212","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"12","key":"9356_CR16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/92.12.1006","volume":"92","author":"AM Goldstein","year":"2000","unstructured":"Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA (2000) Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 92(12):1006\u20131010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"9356_CR17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","volume":"74","author":"CS Carlson","year":"2004","unstructured":"Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74(1):106\u2013120","journal-title":"Am J Hum Genet"},{"key":"9356_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/biomet\/88.4.933","volume":"88","author":"RM Pfeiffer","year":"2001","unstructured":"Pfeiffer RM, Gail MH, Pee D (2001) Inference for covariates that accounts for ascertainment and random genetic effects in family studies. Biometrika 88:16","journal-title":"Biometrika"},{"issue":"1","key":"9356_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42(1):121\u2013130","journal-title":"Biometrics"},{"key":"9356_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2105-7-209","volume":"7","author":"K Allen-Brady","year":"2006","unstructured":"Allen-Brady K, Wong J, Camp NJ (2006) PedGenie: an analysis approach for genetic association testing in extended pedigrees and genealogies of arbitrary size. BMC Bioinformatics 7:209","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"9356_CR21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/gepi.10264","volume":"25","author":"F Dudbridge","year":"2003","unstructured":"Dudbridge F, Koeleman BP (2003) Rank truncated product of P-values, with application to genomewide association scans. Genet Epidemiol 25(4):360\u2013366","journal-title":"Genet Epidemiol"},{"issue":"1","key":"9356_CR22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41(1):28\u201344","journal-title":"Eur J Cancer"},{"issue":"14","key":"9356_CR23","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1073\/pnas.92.14.6489","volume":"92","author":"OI Olopade","year":"1995","unstructured":"Olopade OI, Pomykala HM, Hagos F et al (1995) Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc Natl Acad Sci USA 92(14):6489\u20136493","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9356_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1097-0215(19980105)75:1<51::AID-IJC9>3.0.CO;2-0","volume":"75","author":"Y Hori","year":"1998","unstructured":"Hori Y, Hori H, Yamada Y et al (1998) The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia. Int J Cancer 75(1):51\u201356","journal-title":"Int J Cancer"},{"issue":"4","key":"9356_CR25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000009983","volume":"45","author":"YF Wong","year":"1998","unstructured":"Wong YF, Chung TK, Cheung TH, Nobori T, Chang AM (1998) MTAP gene deletion in endometrial cancer. Gynecol Obstet Invest 45(4):272\u2013276","journal-title":"Gynecol Obstet Invest"},{"issue":"22","key":"9356_CR26","first-page":"6639","volume":"62","author":"SA Christopher","year":"2002","unstructured":"Christopher SA, Diegelman P, Porter CW, Kruger WD (2002) Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a\/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res 62(22):6639\u20136644","journal-title":"Cancer Res"},{"issue":"3","key":"9356_CR27","first-page":"782","volume":"8","author":"JM Garcia-Castellano","year":"2002","unstructured":"Garcia-Castellano JM, Villanueva A, Healey JH et al (2002) Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. Clin Cancer Res 8(3):782\u2013787","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9356_CR28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)63695-4","volume":"163","author":"I Behrmann","year":"2003","unstructured":"Behrmann I, Wallner S, Komyod W et al (2003) Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 163(2):683\u2013690","journal-title":"Am J Pathol"},{"issue":"14","key":"9356_CR29","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1158\/0008-5472.CAN-09-0145","volume":"69","author":"Y Kadariya","year":"2009","unstructured":"Kadariya Y, Yin B, Tang B et al (2009) Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. Cancer Res 69(14):5961\u20135969","journal-title":"Cancer Res"},{"issue":"4","key":"9356_CR30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0891-5849(95)02111-6","volume":"20","author":"S Toyokuni","year":"1996","unstructured":"Toyokuni S (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20(4):553\u2013566","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"9356_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mrfmmm.2003.08.023","volume":"533","author":"X Huang","year":"2003","unstructured":"Huang X (2003) Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 533(1\u20132):153\u2013171","journal-title":"Mutat Res"},{"issue":"4","key":"9356_CR32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/01635580902803701","volume":"61","author":"D Pra","year":"2009","unstructured":"Pra D, Rech Franke SI, Pegas Henriques JA, Fenech M (2009) A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer 61(4):415\u2013426","journal-title":"Nutr Cancer"},{"issue":"4","key":"9356_CR33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/76.4.605","volume":"76","author":"RG Stevens","year":"1986","unstructured":"Stevens RG, Beasley RP, Blumberg BS (1986) Iron-binding proteins and risk of cancer in Taiwan. J Natl Cancer Inst 76(4):605\u2013610","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9356_CR34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910410507","volume":"41","author":"JV Selby","year":"1988","unstructured":"Selby JV, Friedman GD (1988) Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 41(5):677\u2013682","journal-title":"Int J Cancer"},{"issue":"3","key":"9356_CR35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ijc.2910560312","volume":"56","author":"RG Stevens","year":"1994","unstructured":"Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS (1994) Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56(3):364\u2013369","journal-title":"Int J Cancer"},{"issue":"3","key":"9356_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ijc.2910560315","volume":"56","author":"P Knekt","year":"1994","unstructured":"Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T (1994) Body iron stores and risk of cancer. Int J Cancer 56(3):379\u2013382","journal-title":"Int J Cancer"},{"issue":"7","key":"9356_CR37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/oxfordjournals.aje.a117698","volume":"142","author":"LJ Herrinton","year":"1995","unstructured":"Herrinton LJ, Friedman GD, Baer D, Selby JV (1995) Transferrin saturation and risk of cancer. Am J Epidemiol 142(7):692\u2013698","journal-title":"Am J Epidemiol"},{"key":"9356_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1306.001","volume":"1012","author":"K Pantopoulos","year":"2004","unstructured":"Pantopoulos K (2004) Iron metabolism and the IRE\/IRP regulatory system: an update. Ann NY Acad Sci 1012:1\u201313","journal-title":"Ann NY Acad Sci"},{"issue":"13","key":"9356_CR39","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1158\/0008-5472.CAN-09-0112","volume":"69","author":"KH Zhang","year":"2009","unstructured":"Zhang KH, Tian HY, Gao X et al (2009) Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res 69(13):5340\u20135348","journal-title":"Cancer Res"},{"issue":"2","key":"9356_CR40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1078-0432.CCR-07-1054","volume":"14","author":"J Boult","year":"2008","unstructured":"Boult J, Roberts K, Brookes MJ et al (2008) Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma. Clin Cancer Res 14(2):379\u2013387","journal-title":"Clin Cancer Res"},{"issue":"8","key":"9356_CR41","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1478-3231.2006.01316.x","volume":"26","author":"P Holmstrom","year":"2006","unstructured":"Holmstrom P, Gafvels M, Eriksson LC et al (2006) Expression of iron regulatory genes in a rat model of hepatocellular carcinoma. Liver Int 26(8):976\u2013985","journal-title":"Liver Int"},{"issue":"9","key":"9356_CR42","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1158\/1078-0432.CCR-04-0631","volume":"11","author":"A Baldi","year":"2005","unstructured":"Baldi A, Lombardi D, Russo P et al (2005) Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress. Clin Cancer Res 11(9):3175\u20133183","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9356_CR43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3181\/0807-RM-227","volume":"234","author":"MG Tan","year":"2009","unstructured":"Tan MG, Kumarasinghe MP, Wang SM, Ooi LL, Aw SE, Hui KM (2009) Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med (Maywood) 234(6):693\u2013702","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"9356_CR44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/carcin\/bgl210","volume":"28","author":"G Chen","year":"2007","unstructured":"Chen G, Fillebeen C, Wang J, Pantopoulos K (2007) Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts. Carcinogenesis 28(4):785\u2013791","journal-title":"Carcinogenesis"},{"issue":"5","key":"9356_CR45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/CMR.0b013e32830658b2","volume":"18","author":"F Gu","year":"2008","unstructured":"Gu F, Qureshi AA, Niu T et al (2008) Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Melanoma Res 18(5):330\u2013335","journal-title":"Melanoma Res"},{"issue":"1","key":"9356_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.gene.6363726","volume":"2","author":"WM Howell","year":"2001","unstructured":"Howell WM, Turner SJ, Bateman AC, Theaker JM (2001) IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2(1):25\u201331","journal-title":"Genes Immun"},{"issue":"3","key":"9356_CR47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00262-006-0193-z","volume":"56","author":"PN Nikolova","year":"2007","unstructured":"Nikolova PN, Pawelec GP, Mihailova SM et al (2007) Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol Immunother 56(3):371\u2013379","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"9356_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.det.2005.08.003","volume":"24","author":"KK Hanneman","year":"2006","unstructured":"Hanneman KK, Cooper KD, Baron ED (2006) Ultraviolet immunosuppression: mechanisms and consequences. Dermatol Clin 24(1):19\u201325","journal-title":"Dermatol Clin"},{"issue":"39","key":"9356_CR49","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1038\/sj.onc.1207857","volume":"23","author":"Z Shan","year":"2004","unstructured":"Shan Z, Parker T, Wiest JS (2004) Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene 23(39):6612\u20136620","journal-title":"Oncogene"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9356-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9356-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9356-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T02:13:54Z","timestamp":1591409634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9356-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,24]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9356"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9356-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,24]]}}}